Literature DB >> 6268691

Binding of solubilized human TSH-receptor protein by peripheral blood lymphocytes of patients with Graves' disease.

B Wenzel, K W Wenzel, P Kotulla, H Schleusener.   

Abstract

Peripheral blood lymphocytes (PBL) from patients with hyperthyroidism due to Graves' disease (GD) were investigated for the ability to bind radioiodinated TSH receptor protein as hypothetical autoantigen (ABL). Thyrotropin-displacing antibody (TDA)-positive patients, who relapsed and were investigated shortly after starting antithyroid drug therapy, as well as TDA-positive patients with a first diagnosis of GD, who were investigated before starting therapy, showed significantly increased numbers of ABLs (0.2 +/- 0.17%, p less than 0.01 and 0.15 +/- 0.08%, p less than 0.001, respectively) when compared to controls (0.018 +/- 0.016%). In contrast, TDA - negative patients had no significant increase of ABLs (0.08 +/- 0.09%). Preincubation of PBLs with excess unlabelled antigen and nylon wool filtration of PBLs, reduced the number of ABLs markedly. Blocking of the binding sites on the lymphocytes with anti-Ig serum and blocking of the antigen itself by TSH depleted PBLs almost totally from ABLs. The present data indicate that: i) there are lymphocytes of B-cell characteristics capable of binding TSH-receptor; ii) there is a correlation between appearance of ABLs in hyperthyroid GD patients and the detection of TDA in patients' sera; iii) in Hashimoto, toxic nodular goiter and in some normals, a small amount of TSH receptor binding ABLs are detectable.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268691     DOI: 10.1007/BF03350445

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  Preparation of coated radioautographs by dipping sections in fluid emulsion.

Authors:  B MESSIER; C P LEBLOND
Journal:  Proc Soc Exp Biol Med       Date:  1957-10

2.  Evidence that the TSH receptor acts as a mitogenic antigen in Graves' disease.

Authors:  T Mäkinen; G Wägar; L Apter; E von Willebrand; F Pekonen
Journal:  Nature       Date:  1978-09-28       Impact factor: 49.962

3.  Interaction of thyroid-stimulating antibodies with the human thyrotrophin receptor.

Authors:  B R Smith; G A Pyle; V B Petersen; R Hall
Journal:  J Endocrinol       Date:  1977-12       Impact factor: 4.286

4.  The role of autoimmunity in hypoendocrine and hyperendocrine function: with special emphasis on autoimmune thyroid disease.

Authors:  R Volpé
Journal:  Ann Intern Med       Date:  1977-07       Impact factor: 25.391

5.  Metastatic thyroid carcinoma provoking hyperthyroidism, with elevated circulating thyrostimulators.

Authors:  L Valenta; T Lemarchand-Béraud; J Nĕmec; M Griessen; J Bednár
Journal:  Am J Med       Date:  1970-01       Impact factor: 4.965

6.  Validation of autoradiography for recognition of antigen-binding lymphocytes in blood and lymphoid tissues. Quantitation and specificity of binding.

Authors:  J M Dwyer; I R Mackay
Journal:  Clin Exp Immunol       Date:  1972-04       Impact factor: 4.330

7.  Molecular theology, immunophilosophy, and autoimmune disease.

Authors:  H H Fudenberg
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

8.  Receptors on immunocompetent cells. II. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding lymphocytes of normal guinea pigs.

Authors:  J M Davie; W E Paul
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

9.  Thyroid stimulating antibodies and metastatic thyroid carcinoma.

Authors:  M H Snow; T Davies; B R Smith; W M Ross; R G Evans; C S Teng; R Hall
Journal:  Clin Endocrinol (Oxf)       Date:  1979-04       Impact factor: 3.478

10.  Release of thyrotropin receptor from thyroid plasma membranes: effect of hydrocortisone, propranolol, and adenosine 3',5'-monophosphate.

Authors:  K Hashizume; L J DeGroot
Journal:  Endocrinology       Date:  1980-05       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.